Literature DB >> 35729457

Basal Cell Carcinoma: A Narrative Review on Contemporary Diagnosis and Management.

Piyu Parth Naik1, Munaf B Desai2,3.   

Abstract

Basal cell carcinoma (BCC) is the most common, accounting for 80-90% of skin cancers. It arises from the basal layer of the epidermis and its appendages. A complex interplay of environmental, phenotypic and genetic variables leads to the development of BCC. Literature has documented several clinical subtypes of BCC, the most common of which are nodular, superficial and morpheaform. Expeditious diagnosis and analysis are essential for improving the outcome of BCC. Preventive measures, particularly when implemented in childhood and adolescence, may play a critical role. Due to its low metastatic potential, treatment for BCC mostly focuses on local management. The standard treatment of basal cell carcinoma involved complete removal of the lesion by excision or Mohs surgery. In special circumstances, basal cell carcinoma can be treated with cryosurgery, electrodesiccation and curettage, topical medications and photodynamic therapy. This review aimed to evaluate the contemporary diagnosis and management of basal cell carcinoma.
© 2022. The Author(s).

Entities:  

Keywords:  Basal cell carcinoma; Diagnosis; Management; Surgical excision

Year:  2022        PMID: 35729457     DOI: 10.1007/s40487-022-00201-8

Source DB:  PubMed          Journal:  Oncol Ther        ISSN: 2366-1089


  87 in total

1.  Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years.

Authors:  Leslie J Christenson; Theresa A Borrowman; Celine M Vachon; Megha M Tollefson; Clark C Otley; Amy L Weaver; Randall K Roenigk
Journal:  JAMA       Date:  2005-08-10       Impact factor: 56.272

2.  Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For The Skin Cancer Prevention Study Group.

Authors:  M R Karagas; J A McDonald; E R Greenberg; T A Stukel; J E Weiss; J A Baron; M M Stevens
Journal:  J Natl Cancer Inst       Date:  1996-12-18       Impact factor: 13.506

3.  Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012.

Authors:  Howard W Rogers; Martin A Weinstock; Steven R Feldman; Brett M Coldiron
Journal:  JAMA Dermatol       Date:  2015-10       Impact factor: 10.282

4.  Basal cell carcinoma: pathophysiology.

Authors:  Virendra N Sehgal; Kingshuk Chatterjee; Deepika Pandhi; Ananta Khurana
Journal:  Skinmed       Date:  2014 May-Jun

Review 5.  Epidemiology of skin cancer in the mature patient.

Authors:  Vivien Lai; William Cranwell; Rodney Sinclair
Journal:  Clin Dermatol       Date:  2017-10-13       Impact factor: 3.541

Review 6.  Epidemiology of basal cell carcinoma: scholarly review.

Authors:  J A C Verkouteren; K H R Ramdas; M Wakkee; T Nijsten
Journal:  Br J Dermatol       Date:  2017-02-20       Impact factor: 9.302

Review 7.  Incidence and prevalence of non-melanoma skin cancer in Australia: A systematic review.

Authors:  Eshini Perera; Neiraja Gnaneswaran; Carolyn Staines; Aung Ko Win; Rod Sinclair
Journal:  Australas J Dermatol       Date:  2015-02-25       Impact factor: 2.875

8.  Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma.

Authors:  Ximena Bonilla; Laurent Parmentier; Bryan King; Fedor Bezrukov; Gürkan Kaya; Vincent Zoete; Vladimir B Seplyarskiy; Hayley J Sharpe; Thomas McKee; Audrey Letourneau; Pascale G Ribaux; Konstantin Popadin; Nicole Basset-Seguin; Rouaa Ben Chaabene; Federico A Santoni; Maria A Andrianova; Michel Guipponi; Marco Garieri; Carole Verdan; Kerstin Grosdemange; Olga Sumara; Martin Eilers; Iannis Aifantis; Olivier Michielin; Frederic J de Sauvage; Stylianos E Antonarakis; Sergey I Nikolaev
Journal:  Nat Genet       Date:  2016-03-07       Impact factor: 38.330

9.  Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer. I. Basal cell carcinoma.

Authors:  R P Gallagher; G B Hill; C D Bajdik; S Fincham; A J Coldman; D I McLean; W J Threlfall
Journal:  Arch Dermatol       Date:  1995-02

10.  Photosensitizing agents and the risk of non-melanoma skin cancer: a population-based case-control study.

Authors:  Sarah N Robinson; Michael S Zens; Ann E Perry; Steven K Spencer; Eric J Duell; Margaret R Karagas
Journal:  J Invest Dermatol       Date:  2013-01-23       Impact factor: 8.551

View more
  1 in total

Review 1.  Multimodal Considerations Concerning Basal Cell Carcinoma Clefting - Profile of Structural and Aggressive Traits - Perspectives.

Authors:  Elena Niculet; Carmen Bobeica; Alin Codrut Nicolescu; Cristian Onisor; Manuela Arbune; Mihaela Craescu; George Tocu; Alin Laurentiu Tatu
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-09-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.